|Day Low/High||219.21 / 221.65|
|52 Wk Low/High||184.50 / 261.27|
Doug Kass shares his thoughts on whether there's any there, there, and reveals some recent trades.
Markets start to recover from one really bad day amid more political turmoil. Portfolio moves include initiating a position in an ETF.
What's right for a hedge fund manager sitting on a big gain, isn't necessarily right for you.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said earnings matter more than a Citigroup note saying that Pfizer may buy Allergan.
Carl Icahn exited his positions in Allergan and Nuance Communications during the first quarter of the year and acquired a stake in a Xerox spinoff after pressuring for a split.
Akebia Therapeutics, Editas Medicine and Novavax were among the biotech movers in premarket trading on Tuesday.
-- Approximately Half of Americans Surveyed Notice the Eyes First, Supporting the Mission of the Campaign to Empower Chronic Dry Eye Sufferers to Take Action --
Doug Kass shares his thoughts on Nvidia, Coty and Electronic Arts.
Doug Kass shares his thoughts on Allergan and oil.
Jim Cramer is bullish on STMicroelectronics, Chipotle Mexican Grill, Simpson Manufacturing.
Joe Kiani, founder, chairman and CEO of Masimo, tells Jim Cramer about his company's great earnings.
Adam Selipsky, president and CEO of Tableau Software, tells Jim Cramer about what this visual analytics platform can do for business.
Randy Hogan, chairman and CEO of Pentair, tells Jim Cramer the company will focus on water quality and sustainability.
Jim Cramer discusses Hain and also talks about some rules to follow when a stock breaks down.
Jim Cramer lays out next week's game plan: Tech stocks look strong, but same-store sales are sinking retail.
FBI firing, French election, oil prices, retail earnings -- and, oh yes, the markets -- create a dizzying week. We add to a few portfolio positions.
Jim Cramer says he's amazed that stocks -- and gold, even -- are just yawning at Trump's move to fire FBI Director Comey.
Allergan shares had risen $2.55, or 1.05%, in premarket trading to $244.50.
Or any other news events, for that matter?
TheStreet's Jim Cramer discusses Wednesday's trending stocks including Disney, Yelp, Nvidia, Allergan, Abercrombie & Fitch, Macy's and Kohl's.
TheStreet's Jim Cramer said Goldman Sachs' downgrade of Allergan was not "thoughtful" in terms of the company's fundamentals.